NCT02704923View on ClinicalTrials.gov

Atropine for Preventing Ventilator-Associated Pneumonia

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Ventilator-Associated Pneumonia
Interventions
DRUG

Atropine

Atropine eye drops (1%) administered by sublingual way (2 drops) every 6 hours

DRUG

Placebo

Placebo eye drops characterized by saline administered by sublingual way (2 drops) every 6 hours

All Listed Sponsors
lead

Universidade de Passo Fundo

OTHER

NCT02704923 - Atropine for Preventing Ventilator-Associated Pneumonia | Biotech Hunter | Biotech Hunter